Please login to the form below

Not currently logged in
Email:
Password:

fast track appraisal

This page shows the latest fast track appraisal news and features for those working in and with pharma, biotech and healthcare.

NICE first fast-track appraisal backs Bayer's Eylea

NICE first fast-track appraisal backs Bayer's Eylea

NICE first fast-track appraisal backs Bayer's Eylea. But company will have to reduce its cost through a patient access scheme. ... The National Institute for Health and Care Excellence (NICE) has issued its first fast-track guidance, recommending

Latest news

  • NICE to create fast track for most cost-effective new drugs NICE to create fast track for most cost-effective new drugs

    NICE to create fast track for most cost-effective new drugs. Proposes accelerated appraisal process for drugs with QALY of £10, 000 or less. ... Patients could get access to some medicines three months faster under a new 'fast track' appraisal process

  • FDA will give BMS-Pfizer's Eliquis a priority review

    News that the FDA will fast-track its appraisal of the drug comes shortly after UK cost-effectiveness watchdog the National Institute for Health and Clinical Excellence (NICE) issued final draft ... This too was after a fast-tracked review process.

  • NICE recommends BMS-Pfizer's Eliquis after fast-track appraisal

    NICE recommends BMS-Pfizer's Eliquis after fast-track appraisal. Final draft guidance backs Bristol-Myers Squibb and Pfizer's anticoagulant to prevent venous thromboembolism in adults. ... The Institute produced its final draft guidance after a

  • NICE issues final guidance on liraglutide

    As part of its Single Technology Appraisal (STA) process to "fast track" appraisals of single technologies for single indications, the National Institute for Health and Clinical Excellence (NICE) has published final

  • NHS news in brief

    NICE fast-track procedure for 'life-saving' drugs. UK regulatory watchdog the National Institute for Health and Clinical Excellence is carrying out a three-month consultation on plans to introduce a ... fast-track drug appraisal system.

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics